Correlation
The correlation between EMKR and NVO is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
EMKR vs. NVO
Compare and contrast key facts about EMCORE Corporation (EMKR) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EMKR or NVO.
Performance
EMKR vs. NVO - Performance Comparison
Loading data...
Key characteristics
Fundamentals
EMKR:
$28.11M
NVO:
$303.58B
EMKR:
-$3.09
NVO:
$3.57
EMKR:
1.08
NVO:
1.26
EMKR:
0.35
NVO:
1.00
EMKR:
0.62
NVO:
14.65
EMKR:
$61.44M
NVO:
$303.14B
EMKR:
$15.75M
NVO:
$255.65B
EMKR:
-$15.61M
NVO:
$154.08B
Returns By Period
EMKR
N/A
N/A
N/A
N/A
N/A
N/A
N/A
NVO
-15.54%
7.60%
-31.97%
-45.09%
10.66%
18.68%
11.78%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EMKR vs. NVO — Risk-Adjusted Performance Rank
EMKR
NVO
EMKR vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for EMCORE Corporation (EMKR) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
EMKR vs. NVO - Dividend Comparison
EMKR has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.25%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EMKR EMCORE Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 17.24% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.25% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
EMKR vs. NVO - Drawdown Comparison
Loading data...
Volatility
EMKR vs. NVO - Volatility Comparison
Loading data...
Financials
EMKR vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between EMCORE Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EMKR vs. NVO - Profitability Comparison
EMKR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, EMCORE Corporation reported a gross profit of 6.27M and revenue of 19.31M. Therefore, the gross margin over that period was 32.5%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a gross profit of 65.20B and revenue of 78.09B. Therefore, the gross margin over that period was 83.5%.
EMKR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, EMCORE Corporation reported an operating income of -5.46M and revenue of 19.31M, resulting in an operating margin of -28.3%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported an operating income of 38.79B and revenue of 78.09B, resulting in an operating margin of 49.7%.
EMKR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, EMCORE Corporation reported a net income of -5.51M and revenue of 19.31M, resulting in a net margin of -28.6%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a net income of 29.03B and revenue of 78.09B, resulting in a net margin of 37.2%.